22-hydroxycholesterol has been researched along with Dermatitis, Irritant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, JL; Elias, PM; Feingold, KR; Fluhr, JW; Fowler, AJ; Kao, J; Mangelsdorf, DJ; Rhein, L; Schmuth, M; Sheu, MY; Willson, TM | 1 |
1 other study(ies) available for 22-hydroxycholesterol and Dermatitis, Irritant
Article | Year |
---|---|
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Carcinogens; Dermatitis, Irritant; Disease Models, Animal; DNA-Binding Proteins; Epidermis; Female; Hydroxycholesterols; Interleukin-1; Liver X Receptors; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Orphan Nuclear Receptors; Oxazolone; Receptors, Cytoplasmic and Nuclear; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2003 |